KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
4.170
+0.100 (2.46%)
Jul 30, 2026, 2:57 PM EDT - Market open
KORU Medical Systems Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.77 | 8.87 | 9.58 | 11.48 | 17.41 | 25.33 |
Cash & Short-Term Investments | 8.77 | 8.87 | 9.58 | 11.48 | 17.41 | 25.33 |
Cash Growth | 0.37% | -7.40% | -16.56% | -34.04% | -31.29% | -7.25% |
Accounts Receivable | - | - | - | 4.05 | 3.56 | 3.59 |
Other Receivables | 0.34 | 0.32 | 0.28 | 0.03 | 0.97 | 0.72 |
Total Trade Receivables | 0.34 | 0.32 | 0.28 | 4.07 | 4.53 | 4.31 |
Inventory | 4.48 | 3.68 | 2.8 | 3.48 | 6.4 | 6.11 |
Other Current Assets | 1.03 | 0.91 | 0.75 | 1.22 | 1.46 | 1.57 |
Total Current Assets | 20.59 | 19.99 | 19.13 | 20.26 | 29.8 | 37.32 |
Net Property, Plant & Equipment | 7.19 | 7.43 | 7.26 | 7.35 | 7.67 | 1.2 |
Other Intangible Assets | - | - | - | 0.75 | 0.79 | 0.81 |
Other Long-Term Assets | 0.1 | 0.1 | 0.1 | 0.1 | 4.07 | 1.96 |
Total Assets | 28.59 | 28.2 | 27.22 | 28.46 | 42.33 | 41.29 |
Accounts Payable | 2.64 | 2.27 | 1.65 | 0.98 | 2.39 | 1.23 |
Accrued Expenses | 5.66 | 5.36 | 4.74 | 2.17 | 3.43 | 2.87 |
Short-Term Debt | - | - | 0.27 | 0.31 | 0.43 | 0.51 |
Current Portion of Leases | 0.55 | 0.54 | 0.52 | 0.48 | 0.44 | 0.1 |
Other Current Liabilities | 0.01 | 0.03 | 0.03 | 0.51 | 0.26 | 0.09 |
Total Current Liabilities | 8.85 | 8.19 | 7.2 | 4.45 | 6.96 | 4.79 |
Long-Term Leases | 2.82 | 2.96 | 3.2 | 3.65 | 4.05 | - |
Total Long-Term Liabilities | 2.82 | 2.96 | 3.2 | 3.65 | 4.05 | - |
Total Liabilities | 11.67 | 11.15 | 10.4 | 8.11 | 11.01 | 4.79 |
Common Stock | 0.5 | 0.5 | 0.49 | 0.49 | 0.49 | 0.48 |
Treasury Stock | -5.55 | -3.88 | -3.88 | -3.84 | -3.84 | -3.84 |
Additional Paid-in Capital | 54.8 | 52.45 | 49.58 | 47.02 | 44.25 | 40.77 |
Retained Earnings | -32.82 | -32.02 | -29.38 | -23.31 | -9.57 | -0.91 |
Shareholders' Equity | 16.92 | 17.05 | 16.81 | 20.35 | 31.33 | 36.5 |
Total Liabilities & Equity | 28.59 | 28.2 | 27.22 | 28.46 | 42.33 | 41.29 |
Total Debt | 3.37 | 3.5 | 3.99 | 4.45 | 4.93 | 0.6 |
Net Cash (Debt) | 5.4 | 5.38 | 5.59 | 7.04 | 12.48 | 24.73 |
Net Cash Growth | 7.93% | -3.84% | -20.55% | -43.63% | -49.52% | -8.66% |
Net Cash Per Share | 0.12 | 0.12 | 0.12 | 0.15 | 0.28 | 0.56 |
Book Value | 16.92 | 17.05 | 16.81 | 20.35 | 31.33 | 36.5 |
Book Value Per Share | 0.37 | 0.37 | 0.37 | 0.45 | 0.70 | 0.82 |
Tangible Book Value | 16.92 | 17.05 | 16.81 | 19.6 | 30.54 | 35.69 |
Tangible Book Value Per Share | 0.37 | 0.37 | 0.37 | 0.43 | 0.68 | 0.80 |